Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (25)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prakash, M.
Right arrow Articles by Atwood, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prakash, M.
Right arrow Articles by Atwood, J. E.
(Chest. 2001;120:1003-1013.)
© 2001 American College of Chest Physicians

Clinical and Exercise Test Predictors of All-Cause Mortality*

Results From > 6,000 Consecutive Referred Male Patients

Manish Prakash, MD; Jonathan Myers, PhD; Victor F. Froelicher, MD; Rachel Marcus, MD; Dat Do, MD; Damayanthi Kalisetti, MD and J. Edwin Atwood, MD

* From the Division of Cardiovascular Medicine, Stanford University Medical Center and the University of California Irvine, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA.

Correspondence to: Victor Froelicher, MD, Cardiology Division (111C), Veterans Affairs Palo Alto Health Care System, 3801 Miranda Ave, Palo Alto, CA 94304; e-mail: vicmd{at}aol.com


    Abstract
 TOP
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Summary
 References
 
Objective: To report the prevalence of abnormal treadmill test responses and their association with mortality in a large consecutive series of patients referred for standard exercise tests, with testing performed and reported in a standardized fashion.

Background: Exercise testing is widely performed, but few databases exist of large numbers of consecutive tests performed on patients referred for routine clinical purposes using standardized methods. Even fewer of the available databases have information regarding all-cause mortality as an outcome.

Methods: All patients referred for evaluation at two university-affiliated Veterans Affairs medical centers who underwent exercise treadmill testing for clinical indications between 1987 and 2000 were determined to be dead or alive using the Social Security death index after a mean 6.2 years (median, 7 years) of follow-up. Clinical and exercise test variables were collected prospectively according to standard definitions; testing and data management were performed in a standardized fashion using a computer-assisted protocol. All-cause mortality was utilized as the end point for follow-up. Standard survival analysis was performed, including Kaplan-Meier curves and a Cox hazard model.

Results: There were 6,213 male patients (mean ± SD age, 59 ± 11 years) who underwent standard exercise ECG treadmill testing over the study period with a mean follow-up duration of 6.2 ± 3.7 years. There were no complications of testing in this clinically referred population, 78% of whom were referred for chest pain, or risk factors or signs or symptoms of ischemic heart disease. Overlapping thirds had typical angina or history of myocardial infarction (MI). Five hundred seventy-nine patients had prior coronary artery bypass surgery, and 522 patients had a history of congestive heart failure (CHF). Indications for testing were in accordance with published guidelines. Twenty percent died over the follow-up period, for an average annual mortality rate of 2.6%. Cox hazard function chose the following variables in rank order as independently and significantly associated with time to death: exercise capacity (metabolic equivalents < 5, age > 65 years, history of CHF, and history of MI. A score based on these variables (summing up the four variables [if yes = 1 point]) classified patients into low-risk, medium-risk, and high-risk groups. The high-risk group (score >= 3) has a hazard ratio of 5.0 (95% confidence interval, 4.7 to 5.3) and a 5-year mortality rate of 31%.

Conclusion: This comprehensive analysis provides rates of various abnormal responses that can be expected in patients referred for exercise testing at a typical medical center. Four simple variables combined as a score powerfully stratified patients according to prognosis.

Key Words: coronary artery disease • exercise testing • prognosis


    Introduction
 TOP
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Summary
 References
 
Exercise testing is widely used clinically, and its many applications are the subject of a number of national1 2 and international guidelines.3 4 All of the guidelines relative to ischemic heart disease recommend the standard exercise test as the first choice for the evaluation of the patient who presents with chest pain and does not have resting ECG abnormalities that affect the interpretation of the exercise ECG response.5 6 Because the literature lacks a broad picture of treadmill test utilization, it is important to present a large clinical series of consecutive patients presenting for a standard exercise test. The results can be used to provide the prevalence of unusual responses such as ST-segment elevation, exertional hypotension, bundle branch block, and ventricular tachycardia. Multicenter studies have presented treadmill results from large samples of patients. However, the patients are highly selected to fit the study protocol (Coronary Artery Surgical Study,7 Quantitative Exercise Testing and Angiography Study Group 8 ), and series from institutions (Duke,9 Mayo,10 and Cleveland Clinics11 ) consist of target populations to answer specific research questions. Other large databases of treadmill tests with follow-up consist of asymptomatic individuals (US Air Force,12 Cooper Clinic,13 Israeli Air Force14 ) rather than clinical patients. Analysis of a large, clinically referred, consecutive population also provides an opportunity to compare our indications and methods to exercise laboratories throughout the Veterans Affairs (VA) medical system. The latter is possible since we have assessed the behavior of VA exercise laboratories using questionnaires.15 Moreover, the easy availability of Social Security death index data now readily available on the World Wide Web makes it possible to evaluate predictors of all-cause mortality. The purpose of the present study was to report the statistical distribution of treadmill test responses and their association with mortality in a large consecutive series of patients referred for standard exercise tests, with testing performed and reported in a standardized fashion.


    Materials and Methods
 TOP
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Summary
 References
 
Population
The population consisted of consecutive patients referred to two clinical exercise laboratories (Long Beach VA, from 1987 to 1991; Palo Alto VA, 1992 to 2000) directed in consistent fashion by two of the authors (V.F.F. and J.M.). Patients who were subjects in research protocols were not considered in the analyses.

Data Collection
No imaging modality was performed in conjunction with the tests; however, expired gases were measured in approximately one fifth of patients. Both laboratories had affiliations with universities and had academic medical staffs with rotating house officers and fellows. All tests were supervised directly by these individuals or by nurse practitioners; all tests were overread by two of the investigators (V.F.F. and J.M.). A thorough clinical history, listing of medications, and risk factors were recorded prospectively at the time of exercise treadmill testing using computerized forms beginning in 1987.16 17 The forms included standard definitions of clinical conditions and exercise responses.

Exercise Testing
Patients underwent symptom-limited treadmill testing using the US Air Force School of Aerospace Medicine protocol18 or an individualized ramp treadmill protocol.19 Before ramp testing, the patients answered a questionnaire to estimate their exercise capacity; this allowed most patients to reach maximal exercise within the recommended range of 8 to 12 min.20 Patients were encouraged to only use the handrails for balance. Heart rate targets were not used as an end point or to judge the adequacy of the test. Patients did not perform a cool-down walk but were placed in a supine position as soon as possible after exercise.21 Treatment with medications was neither changed nor stopped prior to testing. After careful skin preparation, a standard 12-lead ECG was obtained before and continuously during exercise and for at least 5 min into recovery.22

Visual ST-segment depression was measured at the J junction and corrected for preexercise ST-segment depression while standing; ST-segment slope was measured over the following 60 ms and classified as upsloping, horizontal, or downsloping. The ST-segment response considered was the most horizontal or downsloping ST-segment depression in any lead except aVR during exercise or recovery. An abnormal response was defined as >= 1 mm of horizontal or downsloping ST-segment depression. Ventricular tachycardia was defined as a run of three or more consecutive premature ventricular contractions (PVCs), as previously described.23 BP was measured manually, and metabolic equivalents (METs) were estimated from treadmill speed and grade.19 Exertional hypotension was coded as either a 10-mm Hg drop in systolic BP (SBP) after a rise, or a drop of 10 mm Hg below standing pretest. An exercise SBP code was considered in which 0 = increase > 40 mm Hg, 1 = 31 to 40 mm Hg, 2 = 21 to 30 mm Hg, 3 = 11 to 20 mm Hg, 4 = 0 to 10 mm Hg, and 5 = drop below standing pretest as previously defined.24 {Delta}s and products were not considered in the analyses. All ECG signals were digitized and stored on compact disks after being recorded (Mortara E-scribe; Milwaukee, WI, or QUEST; Burdick/Spacelabs; Milton WI).

No test result was classified as indeterminate.25 The exercise tests were performed, analyzed, and reported per standard protocol and utilizing a computerized database (EXTRA; Mosby Publishers; Chicago, IL).26 The textual report was automatically downloaded into the VA centralized computer database for distribution.27

Follow-up
The Social Security death index was used to match all of the patients using name and social security number. The index is updated weekly, and current information was used. Death status was determined as of July 2000.

Statistical Methods
Number Crunching System Software (NCSS; Salt Lake City, UT) was used for all statistical analyses after transferring the data from a database (ACCESS; Microsoft; Redmond, WA). Total (all-cause) mortality was used as the end point for follow-up for survival analysis. Censoring was not performed since data regarding subsequent interventions were not available for all patients. Survival analysis was performed using Kaplan-Meier curves to compare variables and cut-points, and the Cox hazard function was used to demonstrate which variables were independently and significantly associated with time to death. Automatic selection of variables was performed with a Z value cutoff of 2 iterations and 20 iterations. Hazard ratios were calculated along with their 95% confidence intervals.


    Results
 TOP
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Summary
 References
 
Population Demographics
This male study population had a mean (± SD) height of 69 ± 4 inches, a mean weight of 191 ± 34 lb, and a mean body mass index (BMI) of 28 ± 9 kg/m2. Patients who died were significantly older and had a lower BMI than survivors. Overall, 74% were white, 9% were Hispanic, and 12% were black. There was no significant difference in the survivorship among the different ethnicities. Average resting heart rate was 78 ± 24 beats/min, with a corresponding mean SBP of 133 ± 22 mm Hg. No significant differences in these parameters were noted between those who survived and those who died. Other relevant variables for the entire population, for those who survived, and for the 1,256 who died over the mean 6.2-year follow-up period (median, 6 years) are presented with significance levels in Table 1 . There was an average annual mortality of 2.6%. Table 2 provides the risk factor data in these groups. Risk factors for coronary disease were not clustered among those who died; in fact, risk factors trended to be clustered in those who survived. Table 3 provides data on the resting ECG. All of the major ECG abnormalities were significantly more prevalent in those who died. Medications for congestive heart failure (CHF), ischemia, and hypertension were more frequently prescribed for those who died. All of the major medical history items were significantly more prevalent in those who died, including typical angina. The prevalence of prior coronary artery bypass surgery was twice the rate in those who died compared to those who survived.


View this table:
[in this window]
[in a new window]

 
Table 1.. Population Characteristics With Univariate Comparison Between Those Who Died and Those Who Survived*

 

View this table:
[in this window]
[in a new window]

 
Table 2.. Risk Factors With Univariate Comparison Between Those Who Died and Those Who Survived*

 

View this table:
[in this window]
[in a new window]

 
Table 3.. Resting ECG Abnormalities With Univariate Comparison Between Those Who Died and Those Who Survived

 
Exercise Test Responses
No major complications were encountered during testing. Results for the entire population, specifically for those who survived and the 1,256 patients who died, along with significance levels for differences are presented in Table 4 . While angina occurred more frequently during the exercise test among those who died, there was only a trend for it to be more common as the reason for stopping the exercise test. Abnormal exercise-induced ST-segment depression, the most common ECG abnormality, occurred in one fourth of our population, and two thirds of the time it was silent or asymptomatic. Both symptomatic and asymptomatic ischemia (ie, ST-segment depression) were significantly more common in those who died. The next most prevalent ECG abnormality was frequent PVCs and/or ventricular tachycardia (three beats in a row or more), and this combined response was significantly more prevalent in those who died. ST-segment elevation was rare but more common over Q waves. ST-segment elevation was more frequent in the patients with Q waves who died, but there was no difference in those without Q waves. Exercise-induced ventricular conduction abnormalities were also rare but more common in those who died.


View this table:
[in this window]
[in a new window]

 
Table 4.. Exercise Test Responses With Univariate Comparison Between Those Who Died and Those Who Survived*

 
There were no major differences in resting heart rate or BP, but hemodynamic measurements during exercise were significantly lower in those who died. Failure to reach the age-predicted heart rate occurred in half the population and was significantly more prevalent in those who died. Exercise-induced hypotension (EIH) was relatively rare but significantly more prevalent in those who died. Both groups gave a similar effort as reflected in the mean Borg scale rating of "very hard" (Borg score of 17). The results for univariate Kaplan-Meier survival curves for selected variables are presented in Figures 1 2 3 and Table 5 .



View larger version (18K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1.. Kaplan-Meier survival curves for key clinical variables and METs. Top left, A: age < 65 years or >= 65 years. Top right, B: medical history of CHF. Bottom left, C: medical history of MI. Bottom right, D: exercise capacity > 5 METs or <= 5 METs. Hx = history.

 


View larger version (12K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2.. Kaplan-Meier survival curves for ECG exercise test responses. Top, A: exercise-induced bundle branch block. Middle, B: exercise-induced ST-segment depression. Bottom, C: exercise-induced frequent PVCs or ventricular tachycardia (VT). See Table 4 for definition of abbreviation.

 


View larger version (12K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3.. Kaplan-Meier survival curves for exercise test responses. Left, A: Duke angina score. Right, B: EIH.

 

View this table:
[in this window]
[in a new window]

 
Table 5.. Univariate Comparison of Individual Variables Using Nonparametric Kaplan-Meier Statistics*

 
Reasons for Testing
The reasons for testing are provided in Table 6 . Seventy-eight percent of patients were tested for evalutation of chest pain, or evaluation of signs or symptoms possibly due to coronary disease, or for elevated risk factors. Those who survived were more likely to be tested for "softer" indications, while those who died were more likely to be tested for symptoms suggestive of an abnormality (ie, arrhythmia, angina).


View this table:
[in this window]
[in a new window]

 
Table 6.. Reason for Testing With Univariate Comparison Between Those Who Died and Those Who Survived

 
Prognostic Score
Using stepwise selection, the proportional hazards model was allowed to build on each variable group. Table 7 lists the chosen clinical variables, and Table 8 lists the exercise variables.


View this table:
[in this window]
[in a new window]

 
Table 7.. Variable Selection for Clinical Variables

 

View this table:
[in this window]
[in a new window]

 
Table 8.. Variable Selection for Exercise Test Variables

 
Among clinical variables, age, CHF, history of MI, and pulmonary disease were significant predictors of death followed by the following ECG variables: left ventricular hypertrophy (LVH), resting ST-segment depression, resting left bundle branch block (LBBB), and resting right bundle branch block (RBBB). The most powerful exercise variables were METs and maximal heart rate. The only BP measurement chosen was an exertional hypotension coding but not a drop below standing pretest. Clinical variables alone were entered first with subsequent additions of exercise variables to arrive at the final model consisting of the following: exercise capacity (METs), age, history of MI and/or Q wave on the ECG, and history of CHF. Notably, exercise-induced ECG abnormalities were not chosen as associated with time until death. The continuous variables (age, METs) were dichotomized using cut-points of 5 for METs and 65 years for age. When only these four variables were entered in the model, the coefficients from the Cox model were 0.67, 0.73, 0.67, and 0.50, respectively, enabling construction of the following score: METs < 5 (1 = yes, 0 = no), plus age > 65 years (1 = yes, 0 = no) plus history of CHF (1 = yes, 0 = no) plus history of MI or Q wave on ECG (1 = yes, 0 = no), as shown in Table 9 . The population was then coded as to how many of these variables each subject had, and univariate survival statistics were performed using Kaplan-Meier survival curves for 0, 1, 2, and 3 or more, since so few patients had all four characteristics.


View this table:
[in this window]
[in a new window]

 
Table 9.. Results of Variable Selection Considering the Best Clinical and Exercise Test Variables

 
The hazard ratios, confidence intervals, and p values for score values are shown in Table 10 , and the Kaplan-Meier survival curves are shown in Figure 4 . The score enabled the identification of a low-risk group (42% of the cohort) with an annual mortality rate of < 1.5%, two intermediate-risk groups (51% of the cohort) with an annual mortality rate from 3 to < 5%, and a high-risk group (7% of the cohort) with an annual mortality rate > 6%.


View this table:
[in this window]
[in a new window]

 
Table 10.. Values for the Score and How They Perform Prognostically

 


View larger version (17K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 4.. Kaplan-Meier survival curves for the score (the score is calculated by summing up the four variables [METs < 5, age > 65 years, history of CHF, and history of MI] with if yes = 1 for each).

 

    Discussion
 TOP
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Summary
 References
 
The present results further define the clinical utility of the exercise test and its diagnostic and prognostic applications. The strengths of this study include an unusually long follow-up period (median, 7 years), the inclusion of all consecutive clinical referrals to two similar academically aligned VA medical centers, and the application of standardized methodology. This study is one of many to document the safety of "symptom and sign"-limited maximal exercise testing. It is important to note that in this relatively high-risk population, trained physicians or nurses were always in direct attendance of the test and one of the senior authors was always available for consultation.

Our clinical indications for the test were consistent with the American College of Cardiology/American Heart Association (ACC/AHA) guidelines2 and were similar to exercise laboratories throughout the VA system.15 The highest percentage of patients who underwent exercise testing in our study were tested for the diagnosis of chest pain or evaluation of possible coronary disease (78%; Table 6 ) fitting the ACC/AHA class 1 indication; ie, there is a general consensus that the tests were justified. Class 1 indications are defined as those assisting with the diagnosis of coronary artery disease, assessing exercise capacity, or estimating prognosis among patients with known heart disease, including predischarge and postdischarge testing after an MI or postrevascularization (percutaneous transluminal coronary angioplasty/stenting and coronary artery bypass surgery). However, a great deal of variation existed in terms of criteria for abnormal results and whether physician presence is required during testing at other VA medical centers.13 We used the same ST-segment response criteria as most other VA medical centers, but only 28% of respondents to our survey used some type of treadmill score, possibly because of the lack of a score as simple as ours.

Our study provides additional data regarding the prevalence of a wide range of exercise test responses and their prognostic impact, and represents the findings among all consecutive clinically referred patients rather than a selected group or a research population. Table 11 provides a comparison with prior studies in regard to the frequency of the reported exercise test responses and mortality.28 Similarities of test responses such as hemodynamics and rates of abnormal responses demonstrate that concerns about the VA not being representative of other populations are unfounded. The higher rates in prior studies for some of the variables are due to the fact that most of their populations were clinically selected to undergo cardiac catheterization (ie, had considerable workup bias).28 The rates of abnormal responses, including ventricular tachycardia, ST-segment elevation, and exertional hypotension emphasize the need for proper training and prioritization of issues for certification of individuals performing exercise testing. In addition, the need for physician supervision needs to be better defined.


View this table:
[in this window]
[in a new window]

 
Table 11.. Prevalence of Major Exercise Test Responses From Prior Follow-up Studies for Comparison With Our Study*

 
While many variables are univariately associated with risk for death, it is somewhat surprising that four simple variables provide the majority of the important prognostic information. Table 12 lists the number of times the major prognostic variables were chosen as significantly and independently predictive of time to death out of the times they were considered in the published prognostic studies.24 29 30 31 32 33 34 35 36 The four most prognostic variables in the present study (age, METs, history of MI, and history of CHF) were well represented in this tabulation.


View this table:
[in this window]
[in a new window]

 
Table 12.. Frequency of Clinical and Exercise Test Variables Chosen as Significantly and Independently Associated With Time Until Death in Nine Previous Prognostic Studies

 
Other exercise variables not chosen in the final multivariate model but found to be univariately significant included maximum heart rate, exercise-induced ST-segment depression, arrhythmias during exercise, and EIH. EIH has been demonstrated in most studies to be associated with either a poor prognosis or a high risk of angiographically documented coronary disease.37 EIH has been associated with cardiac complications during exercise testing, making measurement of BP during testing of utmost importance. In our study, EIH had a relative risk of 1.25 for all-cause mortality. Exercise-induced frequent PVCs (> 6/min) had a relative risk of 1.8, and exercise-induced ST-segment depression had a relative risk of 1.8 for all-cause mortality during the median follow-up period of 7 years. The failure of ventricular tachycardia to be independently predictive is consistent with our previous study.23

The relative unimportance of the ischemic variables may be due to our inability to censor on interventions for ischemia (ie, removal of intervened patients from observation when the intervention occurs during follow-up) and the consideration of all-cause mortality instead of cardiovascular mortality. This may also explain why the ischemic variables included in the Duke score that clearly had diagnostic power38 did not predict all-cause mortality. While all-cause mortality has advantages over cardiovascular mortality as an end point,39 the Duke score was generated using the end points of infarction and cardiovascular death. In addition, interventions such as bypass surgery or catheter procedures were censored in the Duke study (that is, subjects were removed from the survival analysis when interventions occurred). Such censoring should increase the association of ischemic variables with outcome by removing patients whose disease has been alleviated, and thereby would not be as likely to experience the outcome. We did not censor patients based on whether they had a cardiovascular procedure during follow-up because we do not have that information. From a previous study using a similar VA patient population with an annual all-cause mortality of 3%, our group found that 75% of deaths were cardiovascular, and that 6% of patients were censored in follow-up due to bypass surgery.40 If the proportions are similar in our current population, it would not be unreasonable to expect a bias against the predictive power of these variables. The contradictory results could also be due to the more effective methods of treatment currently available for coronary disease.

The use of interventions as end points falsely strengthens the association of ischemic variables with end points since the ischemic responses clinically result in the intervention being performed. While some investigators have justified their use by requiring a time period to expire after the test before using the intervention/procedure as an end point, this still influences the associations between test responses and end points. Another problem has been that variables predicting infarction can be different than those predicting death, so that variables are working against themselves when predicting infarct or death (ie, infarct-free survival).

What do these findings mean to the clinician? First, it should be noted that all studies have population-specific attributes that may be difficult to define. Nevertheless, if the aim is to predict infarct-free survival, the Duke treadmill score may be preferred to ours since censoring was performed and infarct-free survival was predicted. If diagnosis is the issue, either the Duke score or other treadmill diagnostic scores are indicated.41 If diagnosis is known, prognostication using our score can help direct therapy. If diagnosis is not known and prognosis is guarded, then further diagnostic efforts may be indicated. If diagnosis is not determined and a patient is high risk by the score, then risk is likely to be improved by an exercise program and risk factor modification. If prognosis is favorable by our score, perhaps diagnosis is not as important as alleviating symptoms. Our findings strengthen the importance of exercise capacity, a reflection of the integrity of the cardiopulmonary system and a marker of a physically active lifestyle, as an important predictor of survival hopefully because of, but possibly at times in spite of, modern medical treatment.


    Summary
 TOP
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Summary
 References
 
This comparatively long follow-up of a large number of consecutive patients with minimal workup bias referred for exercise testing at two VA medical centers provides rates of abnormal responses that can be expected in clinical exercise laboratories adhering to the ACC/AHA indications for testing. The study has demonstrated the prognostic power of four simple pieces of information: exercise capacity, age, and history and signs of MI and CHF. These variables can be used in a simple additive score to powerfully stratify the expected risk of death after modern medical treatment. Our simple score stratified 42% of our population at low risk (< 1.5% annual mortality), 51% at intermediate risk (3 to 5% annual mortality), and 7% at high risk (> 6% annual mortality). Although ischemic ECG variables and other hemodynamic variables were univariately associated with death, they were not chosen in the hazard model as independently and significantly predictive of time until death. It may well be that modern therapies for these responses and the associated conditions are so good that they are not chosen in the hazard model. While these data are unique in terms of the size of the sample and consistency of methodology, the major limitations of only having all-cause mortality, neither data on MI as an end point nor interventional procedures for censoring, and the lack of women must be kept in mind. Nevertheless, to our knowledge, these data represent the largest series of consecutive male patients referred for a standard exercise test, all tested according to consistent and standardized methodology, and provide further evidence of the importance of exercise capacity as a determinant of prognosis.


    Footnotes
 
Abbreviations: ACC/AHA = American College of Cardiology/American Heart Association; BMI = body mass index; CHF = congestive heart failure; EIH = exercise-induced hypotension; LBBB = left bundle branch block; LVH = left ventricular hypertrophy; MET = metabolic equivalent; MI = myocardial infarction; PVC = premature ventricular contraction; RBBB = right bundle branch block; SBP = systolic BP; VA = Veterans Affairs

Received for publication December 1, 2000. Accepted for publication February 27, 2001.


    References
 TOP
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Summary
 References
 

  1. Fletcher, GF, Balady, G, Froelicher, VF, et al (1995) Exercise standards: a statement for health professionals from the American Heart Association. Circulation 91,580-615[Free Full Text]
  2. Gibbons, RJ, Balady, GJ, Beasley, JW, et al (1997) ACC/AHA guidelines for exercise testing. J Am Coll Cardiol 30,260-311[CrossRef][ISI][Medline]
  3. Clinical exercise testing with reference to lung diseases: indications, standardization and interpretation strategies; ERS Task Force on Standardization of Clinical Exercise Testing. Eur Respir Soc Eur Respir J 1997; 10:2662–2689
  4. Guidelines for cardiac exercise testing: ESC Working Group on Exercise Physiology, Physiopathology, and Electrocardiography. Eur Heart J 1993; 14:969–988
  5. O’Rourke, RA, Brundage, BH, Froelicher, V, et al (2000) American College of Cardiology/American Heart Association expert consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. Circulation 102,126-140[Free Full Text]
  6. Braunwald, E, Antman, EM, Beasley, JW, et al (2000) ACC/AHA guidelines for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction: executive summary and recommendations. Circulation 102,1193-1209[Free Full Text]
  7. Weiner, DA, McCabe, CH, Ryan, TJ (1983) Prognostic assessment of patients with coronary artery disease by exercise testing. Am Heart J 105,749-755[CrossRef][ISI][Medline]
  8. Froelicher, VF, Lehmann, KG, Thomas, R, et al (1998) The electrocardiographic exercise test in a population with reduced workup bias: diagnostic performance, computerized interpretation, and multivariable prediction. Ann Intern Med 128,965-974
  9. Shaw, LJ, Peterson, ED, Shaw, LK, et al (1998) Use of a prognostic treadmill score in identifying diagnostic coronary disease subgroups. Circulation 98,1622-1630[Abstract/Free Full Text]
  10. Kwok, JM, Miller, TD, Christian, TF, et al (1999) Prognostic value of a treadmill exercise score in symptomatic patients with nonspecific ST-T abnormalities on resting ECG. JAMA 282,1047-1053[Abstract/Free Full Text]
  11. Lauer, MS, Francis, GS, Okin, PM, et al (1999) Impaired chronotropic response to exercise stress testing as a predictor of mortality. JAMA 281,524-529[Abstract/Free Full Text]
  12. Froelicher, VF, Thomas, M, Pillow, C, et al (1974) An epidemiological study of asymptomatic men screened by maximal treadmill testing for latent CAD. Am J Cardiol 34,770-776[CrossRef][Medline]
  13. Gibbons, LW, Cooper, K, Blair, S, et al (2000) Maximal exercise test as a predictor of risk for mortality from coronary heart disease in asymptomatic men. Am J Cardiol 86,53-58[ISI][Medline]
  14. Livschitz, S, Sharabi, Y, Yushin, J, et al (2000) Limited clinical value of exercise stress test for the screening of coronary artery disease in young, asymptomatic adult men Am J Cardiol 86,462-464[CrossRef][ISI][Medline]
  15. Myers, J, Voodi, L, Umann, T, et al (2000) A survey of exercise testing: methods, utilization, interpretation, and safety in the VAHCS. J Cardiopulm Rehabil 20,251-258[CrossRef][Medline]
  16. Ustin, J, Umann, T, Froelicher, V (1994) Data management: a better approach. Physic Comput 12,30-33
  17. Froelicher, V, Shiu, P (1996) Exercise test interpretation system. Physic Comput 14,40-44
  18. Wolthuis, R, Froelicher, VF, Fischer, J, et al (1977) New practical treadmill protocol for clinical use. Am J Cardiol 39,697-700[CrossRef][ISI][Medline]
  19. Myers, J, Buchanan, N, Walsh, D, et al (1991) A comparison of the ramp versus standard exercise protocols. J Am Coll Cardiol 17,1334-1342[Abstract]
  20. Myers, J, Do, D, Herbert, W, et al (1994) A nomogram to predict exercise capacity from a specific activity questionnaire and clinical data. Am J Cardiol 73,591-596[CrossRef][ISI][Medline]
  21. Lachterman, B, Lehmann, KG, Abrahamson, D, et al (1990) "Recovery only" ST-segment depression and the predictive accuracy of the exercise test. Ann Intern Med 112,11-16
  22. Gamble, P, McManus, H, Jensen, D, et al (1984) A comparison of the standard 12-lead electrocardiogram to exercise electrode placement. Chest 85,616-622[Abstract/Free Full Text]
  23. Yang, JC, Wesley, RC, Froelicher, VF (1991) Ventricular tachycardia during routine treadmill testing: risk and prognosis. Arch Intern Med 151,349-353[Abstract]
  24. Morrow, K, Morris, CK, Froelicher, VF, et al (1993) Prediction of cardiovascular death in men undergoing noninvasive evaluation for coronary artery disease. Ann Intern Med 118,689-695[Abstract/Free Full Text]
  25. Reid, M, Lachs, M, Feinstein, A (1995) Use of methodological standards in diagnostic test research. JAMA 274,645-651[Abstract]
  26. Shue, P, Froelicher, V (1998) Extra, an expert system for exercise test reporting. J Noninvas Test II-4,21-27
  27. Froelicher, V, Myers, J (1998) Research as part of clinical practice: use of Windows-based relational databases. Veterans Health System J March,53-57
  28. Froelicher, VF, Myers, J (1999) Exercise and the heart 4th ed. Saunders-Mosby Philadelphia, PA.
  29. Mark, DB, Shaw, L, Harrell, FE, Jr, et al (1991) Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. N Engl J Med 325,849-853[Abstract]
  30. Gohlke, H, Samek, L, Betz, P, et al (1983) Exercise testing provides additional prognostic information in angiographically defined subgroups of patients with coronary artery disease. Circulation 68,979-985[Abstract/Free Full Text]
  31. . for the ODI Study GroupBrunelli, C, Cristofani, R, L’Abbate, A (1989) Long-term survival in medically treated patients with ischemic heart disease and prognostic importance of clinical and electrocardiographic data.: the Italian CNR Multicenter Prospective Study OD1 Eur Heart J 10,292-303[Abstract/Free Full Text]
  32. Weiner, DA, Ryan, T, McCabe, CH, et al (1984) Prognostic importance of a clinical profile and exercise test in medically treated patients with coronary artery disease. J Am Coll Cardiol 3,772-779[Abstract]
  33. Peduzzi, P, Hultgren, H, Thomsen, J, et al (1986) Prognostic value of baseline exercise tests. Prog Cardiovasc Dis 28,285-292[CrossRef][ISI][Medline]
  34. Lerman, J, Svetlize, H, Capris, T, et al (1986) Follow-up of patients after exercise test and catheterization Medicina (Buenos Aires) 46,201-211
  35. Wyns, W, Musschaert-Beauthier, E, Van Domburg, R, et al (1985) Prognostic value of symptom limited exercise testing in men with a high prevalence of coronary artery disease. Eur Heart J 6,939-945[Abstract/Free Full Text]
  36. Detry, JM, Luwaert, J, Melin, J, et al (1988) Non-invasive data provide independent prognostic information in patients with chest pain without previous myocardial infarction: findings in male patients who have had cardiac catheterization. Eur Heart J 9,418-426[Abstract/Free Full Text]
  37. Dubach, P, Froelicher, VF, Klein, J, et al (1988) Exercise-induced hypotension in a male population: criteria, causes, and prognosis. Circulation 78,1380-1387[Abstract/Free Full Text]
  38. Shaw, LJ, Peterson, ED, Shaw, LK, et al (1998) Use of a prognostic treadmill score in identifying diagnostic coronary disease subgroups. Circulation 98,1622-1630
  39. Lauer, MS, Blackstone, EH, Young, JB, et al (1999) Cause of death in clinical research: time for a reassessment? J Am Coll Cardiol 34,618-620[Free Full Text]
  40. Froelicher, VF, Morrow, K, Brown, M, et al (1994) Prediction of atherosclerotic cardiovascular death in men using a prognostic score. Am J Cardiol 73,133-138[CrossRef][ISI][Medline]
  41. Do, D, West, JA, Morise, A, et al (1997) A consensus approach to diagnosing coronary artery disease based on clinical and exercise test data. Chest 111,1742-1749[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
E. Handberg, B. D. Johnson, C. B. Arant, T. R. Wessel, R. A. Kerensky, G. von Mering, M. B. Olson, S. E. Reis, L. Shaw, C. N. Bairey Merz, et al.
Impaired Coronary Vascular Reactivity and Functional Capacity in Women: Results From the NHLBI Women's Ischemia Syndrome Evaluation (WISE) Study
J. Am. Coll. Cardiol., February 7, 2006; 47(3_Suppl_S): S44 - S49.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
C. A Daly, B. De Stavola, J. L L. Sendon, L. Tavazzi, E. Boersma, F. Clemens, N. Danchin, F. Delahaye, A. Gitt, D. Julian, et al.
Predicting prognosis in stable angina--results from the Euro heart survey of stable angina: prospective observational study
BMJ, February 4, 2006; 332(7536): 262 - 267.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
R R T Castro, G Porphirio, S M Serra, and A C L Nobrega
Cholinergic stimulation with pyridostigmine protects against exercise induced myocardial ischaemia
Heart, October 1, 2004; 90(10): 1119 - 1123.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. H. Marwick, C. Case, D. Poldermans, E. Boersma, J. Bax, S. Sawada, and J. D. Thomas
A clinical and echocardiographic score for assigning risk of major events after dobutamine echocardiograms
J. Am. Coll. Cardiol., June 2, 2004; 43(11): 2102 - 2107.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. F. Cohn, K. M. Fox, and C. Daly
Silent Myocardial Ischemia
Circulation, September 9, 2003; 108(10): 1263 - 1277.
[Full Text] [PDF]


Home page
Eur Heart JHome page
C Daly, J Norrie, D.L Murdoch, I Ford, H.J Dargie, K Fox, and for the TIBET study group
The value of routine non-invasive tests to predict clinical outcome in stable angina
Eur. Heart J., March 2, 2003; 24(6): 532 - 540.
[Abstract] [Full Text] [PDF]


Home page
Evid. Based Nurs.Home page
OTHER ARTICLES NOTED (Nov 01 to 18 Oct 02)
Evid. Based Nurs., January 1, 2003; 6(1): e1 - 1.
[Full Text] [PDF]


Home page
JAMAHome page
M. Tanasescu, M. F. Leitzmann, E. B. Rimm, W. C. Willett, M. J. Stampfer, and F. B. Hu
Exercise Type and Intensity in Relation to Coronary Heart Disease in Men
JAMA, October 23, 2002; 288(16): 1994 - 2000.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
R. F. DeBusk, S. Malozowski, J. T. Sahlroot, P. A. Pellikka, and A. M. Arruda-Olson
Sildenafil and Physical Exertion in Men With Coronary Artery Disease
JAMA, May 8, 2002; 287(18): 2359 - 2360.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (25)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prakash, M.
Right arrow Articles by Atwood, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prakash, M.
Right arrow Articles by Atwood, J. E.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS